New drug LW402 put to the test in healthy volunteers
NCT ID NCT07546149
First seen Apr 26, 2026 · Last updated May 22, 2026 · Updated 5 times
Summary
This early-stage study tested the safety and tolerability of an experimental drug called LW402 in 36 healthy volunteers. Participants took multiple doses of the drug or a placebo, and researchers monitored for side effects and how the drug moves through the body. The goal was not to treat any disease, but to gather important safety information before testing in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY EVALUATION OF ESCALATING DOSES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital of Shandong First Medical University
Jinan, Shangdong, China
Conditions
Explore the condition pages connected to this study.